AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION
- PMID: 29320641
- DOI: 10.4158/EP-2017-0053
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION
Abstract
This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.
Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.Endocr Pract. 2018 Mar;24(3):302-308. doi: 10.4158/PS-2017-0155. Endocr Pract. 2018. PMID: 29547046
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK.Endocr Pract. 2015 Sep;21(9):1066-73. doi: 10.4158/EP14434.PS. Endocr Pract. 2015. PMID: 26355962
-
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS. Endocr Pract. 2015. PMID: 26642101
-
Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring.Endocr Pract. 2015 May;21(5):522-33. doi: 10.4158/EP15653.CS. Endocr Pract. 2015. PMID: 25962091
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.Endocr Pract. 2016 Oct;22(10):1235-1244. doi: 10.4158/EP161407.DSCR. Epub 2016 Jul 13. Endocr Pract. 2016. PMID: 27409821 Review.
Cited by
-
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.Diabetologia. 2024 Dec;67(12):2611-2625. doi: 10.1007/s00125-024-06242-0. Epub 2024 Aug 9. Diabetologia. 2024. PMID: 39120767 Free PMC article. Review.
-
Dysautonomia: A Forgotten Condition - Part 1.Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420. Arq Bras Cardiol. 2021. PMID: 33886735 Free PMC article. English, Portuguese.
-
Dysautonomia: A Forgotten Condition - Part II.Arq Bras Cardiol. 2021 May;116(5):981-998. doi: 10.36660/abc.20200422. Arq Bras Cardiol. 2021. PMID: 34008826 Free PMC article. English, Portuguese. No abstract available.
-
Mortality risk factors in newly diagnosed diabetic cardiac autonomic neuropathy.Clin Auton Res. 2023 Dec;33(6):903-907. doi: 10.1007/s10286-023-00975-5. Epub 2023 Sep 11. Clin Auton Res. 2023. PMID: 37695385 No abstract available.
-
Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy.Anatol J Cardiol. 2022 Nov;26(11):832-840. doi: 10.5152/AnatolJCardiol.2022.1934. Anatol J Cardiol. 2022. PMID: 35949125 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical